Specific Lipid and Metabolic Profiles of R-CHOP-Resistant Diffuse Large B-Cell Lymphoma Elucidated by Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging and in Vivo Imaging
Sign Up to like & getrecommendations! Published in 2018 at "Analytical Chemistry"
DOI: 10.1021/acs.analchem.8b02910
Abstract: Diffuse large B-cell lymphoma (DLBCL) is the most common B-cell non-Hodgkin lymphoma. To treat this aggressive disease, R-CHOP, a combination of immunotherapy (R; rituximab) and chemotherapy (CHOP; cyclophosphamide, doxorubicin, vincristine, and prednisone), remains the most… read more here.
Keywords: lymphoma; specific lipid; diffuse large; chop resistant ... See more keywords